First-line Targeted Therapy Failure
1 clinical trials · Condition
◉ Watch First-line Targeted Therapy Failure
| Record | Firm | Date |
|---|---|---|
| Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy (NCT07537777) | Nanfang Hospital, Southern Medical University | 2026-04-20 |
Track First-line Targeted Therapy Failure automatically
Every clearance here is in the API, with alerts when new ones post.